Cited 16 time in
Alpha-lipoic acid ameliorates the epithelial mesenchymal transition induced by unilateral ureteral obstruction in mice
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cho, Hyun Seop | - |
| dc.contributor.author | Kim, Jin Hyun | - |
| dc.contributor.author | Jang, Ha Nee | - |
| dc.contributor.author | Lee, Tae Won | - |
| dc.contributor.author | Jung, Myeong Hee | - |
| dc.contributor.author | Kim, Tae Ho | - |
| dc.contributor.author | Chang, Se-Ho | - |
| dc.contributor.author | Park, Dong Jun | - |
| dc.date.accessioned | 2022-12-26T18:48:00Z | - |
| dc.date.available | 2022-12-26T18:48:00Z | - |
| dc.date.issued | 2017-04-05 | - |
| dc.identifier.issn | 2045-2322 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/13764 | - |
| dc.description.abstract | The epithelial-to-mesenchymal transition (EMT) is one of mechanisms that induce renal interstitial fibrosis. Understanding EMT in renal fibrosis has important therapeutic implications for patients with kidney disease. Alpha-lipoic acid (ALA) is a natural compound with antioxidant properties. Studies for ALA are performed in acute kidney injury with renal tubular apoptosis, renal inflammation, and oxidative stress. We investigated the effects of ALA on EMT-mediated renal interstitial fibrosis in mice with unilateral ureteral obstruction (UUO). UUO mice developed severe tubular atrophy and tubulointerstitial fibrosis, with a robust EMT response and ECM deposition after 7 postoperative days. In contrast, ALA-treated UUO mice showed only moderate injury and minimal fibrosis and also larger reductions in the expression of ECM proteins, inflammatory factors, and EMT markers. ALA was shown to be involved in the suppression of infiltrating macrophages associated with EMT and the progression of interstitial fibrosis. It also lessened the destruction of the tubular basement membrane, by reducing the expression of matrix metalloproteinases. This is the first study to show that ALA modulates EMT in a UUO mouse model. Our results suggest that ALA merits further exploration as a therapeutic agent in the prevention and treatment of chronic kidney disease. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | NATURE RESEARCH | - |
| dc.title | Alpha-lipoic acid ameliorates the epithelial mesenchymal transition induced by unilateral ureteral obstruction in mice | - |
| dc.type | Article | - |
| dc.publisher.location | 독일 | - |
| dc.identifier.doi | 10.1038/srep46065 | - |
| dc.identifier.scopusid | 2-s2.0-85017164077 | - |
| dc.identifier.wosid | 000398399200001 | - |
| dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, v.7 | - |
| dc.citation.title | SCIENTIFIC REPORTS | - |
| dc.citation.volume | 7 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
| dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
| dc.subject.keywordPlus | GROWTH-FACTOR-BETA | - |
| dc.subject.keywordPlus | INTERSTITIAL FIBROSIS | - |
| dc.subject.keywordPlus | RENAL FIBROSIS | - |
| dc.subject.keywordPlus | NEPHROPATHY | - |
| dc.subject.keywordPlus | DISEASE | - |
| dc.subject.keywordPlus | PROGRESSION | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordPlus | INSIGHTS | - |
| dc.subject.keywordPlus | CELLS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
